IBM has announced it will partner with Cleveland Clinic to accelerate the adoption of genomic medicine at the Cleveland Clinic through a cancer care pilot using supercomputer Watson's Genomics Analytics service.
The pilot study will analyze cancer patients' genetics and deliver the results to oncologists to uncover more personalized treatment opportunities for each patient.
The goal of the pilot is to accelerate clinicians' ability to personalize cancer care, which otherwise would be a much slower process, through using Watson's capabilities. Through analyzing patterns in genomic sequencing, the collaboration hopes to uncover knowledge that will improve personalized cancer medicine. The cancer pilot is an added project to IBM's existing collaboration with Cleveland Clinic to advance big data in healthcare, according to a release.
"Using Watson's cognitive computing capabilities, Cleveland Clinic aims to offer cutting-edge care to millions of patients," said Rob Merkel, vice president and IBM Watson Group healthcare leader, in a news release. "We're excited by our continued partnership with Cleveland Clinic. Together we aim to advance a new era of cognitive computing that will aide in the acceleration of new discoveries and bring forward new breakthroughs in personalized medicine."
"We are very pleased with the progress being made and the impact IBM has had in the commercialization of promising genomic medicine technologies," said Gary Fingerhut, Executive Director of Cleveland Clinic Innovations, in the release.
More articles on health IT:
IBM Watson HQ opens in NYC's Silicon Alley
IBM, UPenn launch educational program for analyzing big data